![Aetna Wun Trombley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aetna Wun Trombley
Directeur/Bestuurslid bij Carmot Therapeutics, Inc.
Actieve functies van Aetna Wun Trombley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Directeur/Bestuurslid | 16-08-2016 | - |
Independent Dir/Board Member | 16-08-2016 | - |
Loopbaan van Aetna Wun Trombley
Eerdere bekende functies van Aetna Wun Trombley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NGM BIOPHARMACEUTICALS, INC. | Operationeel Directeur | 01-06-2015 | 13-03-2020 |
Corporate Officer/Principal | 01-01-2011 | - | |
President | 01-09-2018 | 13-03-2020 | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
XENOPORT, INC. | Corporate Officer/Principal | - | - |
Opleiding van Aetna Wun Trombley
MIT Sloan School of Management | Graduate Degree |
University of California San Diego | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
XenoPort, Inc.
![]() XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Carmot Therapeutics, Inc.
![]() Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Health Technology |
- Beurs
- Insiders
- Aetna Wun Trombley
- Ervaring